Controlling schistosomiasis: the cost-effectiveness of alternative delivery strategies.
Sustainable schistosomiasis control cannot be based on large-scale vertical treatment strategies in most endemic countries, yet little is known about the costs and effectiveness of more affordable options. This paper presents calculations of the cost-effectiveness of two forms of chemotherapy targeted at school-children and compares them with chemotherapy integrated into the routine activities of the primary health care system. The focus is on Schistosoma haematobium. Economic and epidemiological data are taken from the Kilombero District of Tanzania. The paper also develops a framework for possible use by programme managers to evaluate similar options in different epidemiological settings. The results suggest that all three options are more affordable and sustainable than the vertical strategies for which cost data are available in the literature. Passive testing and treatment through primary health facilities proved the most effective and cost-effective option given the screening and compliance rates observed in the Kilombero District.
Department of Public Health and Epidemiology, Swiss Tropical Institute, Basel.
H
H
Guyatt
D
D
Evans
C
C
Lengeler
M
M
Tanner
D002648:Child; D002662:Child Health Services / Q000191:economics; D003362:Cost-Benefit Analysis; D003625:Data Collection; D017048:Health Care Costs; D006302:Health Services Research; D006801:Humans; D008403:Mass Screening; D008952:Mobile Health Units / Q000191:economics; D011320:Primary Health Care / Q000191:economics*; D012552:Schistosomiasis / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology; D012572:School Health Services / Q000191:economics; D013636:Tanzania / Q000453:epidemiology